Mohit Bansal

Stock Analyst at Wells Fargo

(1.62)
# 1703
Out of 5,438 analysts
184
Total ratings
Success rate
Average return
35 Stocks
Name Action PT Current % Upside Ratings Updated
VRTX Vertex Pharmaceutica...
Upgrades: Overweight
460 460
374.47 22.84% 11 Aug 6, 2025
BNTX BioNTech
Maintains: Overweight
170 150
109.29 37.25% 2 Aug 5, 2025
MRK Merck & Co
Maintains: Equal-Weight
97 90
80.06 12.42% 11 Jul 30, 2025
REGN Regeneron Pharmaceut...
Downgrades: Equal-Weight
700 580
546.18 6.19% 18 May 30, 2025
XENE Xenon Pharmaceutical...
Maintains: Overweight
50 47
34.12 37.75% 2 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
60 65
62.92 3.31% 7 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 53
45.94 15.37% 9 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
7 1
0.84 19.05% 4 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
970 1100
635.48 73.1% 17 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
120 140
120.57 16.12% 11 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
210 240
198.62 20.83% 8 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
165 140
128.03 9.35% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
130 170
110.76 53.49% 2 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
335 280
285.1 -1.79% 9 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
30
28.23 6.27% 1 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
70
20.18 246.88% 1 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
9 27
17.29 56.16% 4 Oct 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
115 90
56.8 58.45% 5 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
28 30
24.61 21.9% 10 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
140 170
123.99 37.11% 7 Apr 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
30 40
40.39 -0.97% 1 Aug 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
30
44.96 -33.27% 3 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
27
13.2 104.55% 1 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
n/a n/a 1 Jun 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
1875
10.54 17689.37% 1 Mar 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
10.25 241.46% 1 Feb 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 30
30 0% 4 Jan 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
175
182.5 -4.11% 1 Dec 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
0.74 4764.86% 1 Nov 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
125 225
n/a n/a 4 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 19
12.11 56.9% 3 Apr 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 5
n/a n/a 3 Apr 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
160 140
n/a n/a 2 Mar 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
30 60
1.1 5354.55% 4 Dec 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 116
n/a n/a 2 Oct 2, 2017